Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) have a strong clinical, genetic and pathological overlap. This review focuses on the current understanding of structural, functional and molecular neuroimaging signatures of genetic FTD and ALS. We overview quantitative neuroimaging studies on the most common genes associated with FTD (MAPT, GRN), ALS (SOD1), and both (C9orf72), and summarize visual observations of images reported in the rarer genes (CHMP2B, TARDBP, FUS, OPTN, VCP, UBQLN2, SQSTM1, TREM2, CHCHD10, TBK1).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350 · cited 5×
“Task-free fMRI studies in healthy individuals show that the anterior temporal lobe has strong intrinsic connectivity to the anterior cingulate, orbitofrontal cortex, frontoinsula, striatum and thalamus (Guo et al., 2013; Seeley et al., 2009).”
BackgroundInfluentialMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Cruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 3×
“…codons in GRN mRNA that are degraded by nonsense-mediated decay, which results in a haploinsufficiency of progranulin protein (Baker et al., 2006; Cruts et al., 2006), most commonly leading to bvFTD and less frequently PPA, CBS or an Alzheimer's-like amnestic syndrome (Le Ber et al., 2008).”
BackgroundMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Watts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391 · cited 2×
“VCP mutations are associated with a disease characterized by inclusion body myopathy, Paget's disease of bone and early onset FTD (IBMPFD) (Taylor, 2015; Watts et al., 2004) and other clinical syndromes including ALS (Johnson et al., 2010).”
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174
Zhou, J., Greicius, M. D., Gennatas, E. D., Growdon, M. E., Jang, J. Y., Rabinovici, G. D., Kramer, J. H., Weiner, M., Miller, B. L., & Seeley, W. W. (2010) · Brain · doi:10.1093/brain/awq075 · Cited by 1,016
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., Couthouis, J., Lu, Y.-F., Wang, Q., Krueger, B. J., et al. (2015) · Science · doi:10.1126/science.aaa3650 · Cited by 966
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Patterns of brain atrophy in frontotemporal dementia and semantic dementia
Rosen, H. J., Gorno–Tempini, M. L., Goldman, W. P., Perry, R. J., Schuff, N., Weiner, M., Feiwell, R., Kramer, J. H., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.58.2.198 · Cited by 841
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Freischmidt, A., Wieland, T., Richter, B., Ruf, W., Schaeffer, V., Müller, K., Marroquin, N., Nordin, F., Hübers, A., Weydt, P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4000 · Cited by 786
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703 · cited 1×
“While it remains unknown how SOD1 mutations lead to ALS, the mutations cause a toxic gain of function (Rothstein, 2009).”
BackgroundPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
The heritability and genetics of frontotemporal lobar degeneration
Rohrer, J. D., Guerreiro, R., Vandrovcova, J., Uphill, J., Reiman, D., Beck, J., Isaacs, A. M., Authier, A., Ferrari, R., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bf997a · Cited by 536
Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., Jones, M., Gerhard, A., Davidson, Y. S., Robinson, A., et al. (2012) · Brain · doi:10.1093/brain/awr355 · Cited by 523
Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia
Seeley, W. W., Crawford, R., Rascovsky, K., Kramer, J. H., Weiner, M., Miller, B. L., & Gorno-Tempini, M. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.38 · Cited by 506
Structural anatomy of empathy in neurodegenerative disease
Rankin, K. P., Gorno-Tempini, M. L., Allison, S. C., Stanley, C. M., Glenn, S., Weiner, M. W., & Miller, B. L. (2006) · Brain · doi:10.1093/brain/awl254 · Cited by 504 · cited 1×
“temporal lobe, right anterior cingulate, anterior insula, and ventral striatum (Rankin et al., 2006).”
An update on genetic frontotemporal dementia
Greaves, C. V., & Rohrer, J. D. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09363-4 · Cited by 500
Neuroanatomical correlates of behavioural disorders in dementia
Rosen, H. J., Allison, S. C., Schauer, G. F., Gorno-Tempini, M. L., Weiner, M. W., & Miller, B. L. (2005) · Brain · doi:10.1093/brain/awh628 · Cited by 497 · cited 1×
“striatal atrophy, while more complex compulsions correlate with orbitofrontal, temporal lobe, and caudate atrophy (Josephs et al., 2008; Perry et al., 2012; Rosen et al., 2005; Rosso et al., 2001).”
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374 · cited 1×
“TREM2 carriers with a pure FTD diagnosis exhibit frontal and/or temporal atrophy with parietal and hippocampal involvement along with extensive white matter lesions and reduced thickness of the corpus callosum (Giraldo et al., 2013; Guerreiro et al., 2013; Le Ber et al., 2014).”
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345
Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1436-x · Cited by 312
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Rubino, E., Rainero, I., Chiò, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e25df · Cited by 286
Neuropathology of amyotrophic lateral sclerosis and its variants
Saberi, S., Stauffer, J. E., Schulte, D. J., & Ravits, J. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.012 · Cited by 282 · cited 1×
“deposition of misfolded SOD1 protein inclusions in motor neurons (Saberi et al., 2015), and curiously, the TDP-43 pathology that is characteristic of sporadic ALS is absent (Mackenzie et al.”
Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia
Rogalski, E., Cobia, D., Harrison, T. M., Wieneke, C., Weintraub, S., & Mesulam, M.-M. (2011) · Neurology · doi:10.1212/wnl.0b013e31821ccd3c · Cited by 252 · cited 1×
“The anterior temporal lobe, typically more atrophied on the left compared with the right, shows prominent focal degeneration, sometimes with ―knifeedge‖ gyri in patients with severe atrophy (Gorno-Tempini et al., 2004; Rogalski et al., 2011).”
On the right side? A longitudinal study of left- versus right-lateralized semantic dementia
Kumfor, F., Landin-Romero, R., Devenney, E., Hutchings, R., Grasso, R., Hodges, J. R., & Piguet, O. (2016) · Brain · doi:10.1093/brain/awv387 · Cited by 224
Kim, E.-J., Sidhu, M., Gaus, S. E., Huang, E. J., Hof, P. R., Miller, B. L., DeArmond, S. J., & Seeley, W. W. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr004 · Cited by 204 · cited 1×
“rodegeneration starts in the pregenual anterior cingulate and the frontoinsular cortex (Kim et al., 2012; Seeley et al., 2007a, 2008), with”
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study
Cash, D. M., Bocchetta, M., Thomas, D. L., Dick, K. M., van Swieten, J. C., Borroni, B., Galimberti, D., Masellis, M., Tartaglia, M. C., Rowe, J. B., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.008 · Cited by 200
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study
Diehl-Schmid, J., Grimmer, T., Drzezga, A., Bornschein, S., Riemenschneider, M., Förstl, H., Schwaiger, M., & Kurz, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.11.002 · Cited by 199
Yu, C.-E., Bird, T. D., Bekris, L. M., Montine, T. J., Leverenz, J. B., Steinbart, E., Galloway, N. M., Feldman, H., Woltjer, R., Miller, C. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.328 · Cited by 190 · cited 1×
“FTD-ALS has been reported infrequently in association with GRN mutations, and pure ALS is rare (Chen-Plotkin et al., 2011; Yu et al., 2010).”
BackgroundWhite matter damage in frontotemporal lobar degeneration spectrum
Agosta, F., Scola, E., Canu, E., Marcone, A., Magnani, G., Sarro, L., Copetti, M., Caso, F., Cerami, C., Comi, G., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr288 · Cited by 180
Ber, I. L., Guedj, E., Gabelle, A., Verpillat, P., Volteau, M., Thomas-Anterion, C., Decousus, M., Hannequin, D., Vera, P., Lacomblez, L., et al. (2006) · Brain · doi:10.1093/brain/awl288 · Cited by 179
Functional network connectivity in the behavioral variant of frontotemporal dementia
Filippi, M., Agosta, F., Scola, E., Canu, E., Magnani, G., Marcone, A., Valsasina, P., Caso, F., Copetti, M., Comi, G., et al. (2013) · Cortex · doi:10.1016/j.cortex.2012.09.017 · Cited by 177 · cited 1×
“within the salience network (Day et al., 2013; Filippi et al., 2013; Zhou et al., 2010), though some studies report hyperconnectivity or con-”
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Philtjens, S., Heeman, B., Engelborghs, S., Vandenbulcke, M., De Baets, G., Bäumer, V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002220 · Cited by 174 · cited 1×
“Clinically, TBK1 loss-of-function mutations manifest as bvFTD, PPA, and ALS and are associated with TDP-43 type B pathology (Freischmidt et al., 2015; Gijselinck et al., 2015).”
Heterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.017 · Cited by 173
18 F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Smith, R., Puschmann, A., Schöll, M., Ohlsson, T., van Swieten, J., Honer, M., Englund, E., & Hansson, O. (2016) · Brain · doi:10.1093/brain/aww163 · Cited by 168 · cited 1×
“[18F]AV-1451, however, has shown strong binding to neurofibrillary tangles matching the pattern of paired helical filament (PHF) immunochemistry in a subset of MAPT mutations such as V337M and R406W (Jones et al., 2018; Smith et al., 2016; Tsai et al., 2019).”
BackgroundFrontotemporal Dementia Associated With the C9ORF72 Mutation: A Unique Clinical Profile
Devenney, E., Hornberger, M., Irish, M., Mioshi, E., Burrell, J., Tan, R., Kiernan, M. C., & Hodges, J. R. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6002 · Cited by 167
Seeley, W. W., Allman, J. M., Carlin, D. A., Crawford, R. K., Macedo, M. N., Greicius, M. D., DeArmond, S. J., & Miller, B. L. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c0f14 · Cited by 165
Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
Lee, S. E., Sias, A. C., Mandelli, M. L., Brown, J. A., Brown, A. B., Khazenzon, A. M., Vidovszky, A. A., Zanto, T. P., Karydas, A. M., Pribadi, M., et al. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.12.006 · Cited by 165 · cited 4×
“, 2017), and are present even in presymptomatic carriers younger than 40 years old (Bertrand et al., 2018; Le Blanc et al., 2020; Lee et al., 2017).”
InfluentialSelf-citation18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
Tsai, R. M., Bejanin, A., Lesman-Segev, O., LaJoie, R., Visani, A., Bourakova, V., O’Neil, J. P., Janabi, M., Baker, S., Lee, S. E., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0470-7 · Cited by 164
Self-citationC9orf72 repeat expansions are a rare genetic cause of parkinsonism
Lesage, S., Le Ber, I., Condroyer, C., Broussolle, E., Gabelle, A., Thobois, S., Pasquier, F., Mondon, K., Dion, P. A., Rochefort, D., et al. (2013) · Brain · doi:10.1093/brain/aws357 · Cited by 164
Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia
Dopper, E. G. P., Rombouts, S. A. R. B., Jiskoot, L. C., den Heijer, T., de Graaf, J. R. A., de Koning, I., Hammerschlag, A. R., Seelaar, H., Seeley, W. W., Veer, I. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000583 · Cited by 152
SQSTM1 mutations – Bridging Paget disease of bone and ALS/FTLD
Rea, S. L., Majcher, V., Searle, M. S., & Layfield, R. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.020 · Cited by 152 · cited 1×
“The sequestome 1 (SQSTM1) gene encodes for p62, a multi-functional protein that targets specific cargoes for autophagy (Rea et al., 2014).”
Giraldo, M., Lopera, F., Siniard, A. L., Corneveaux, J. J., Schrauwen, I., Carvajal, J., Muñoz, C., Ramirez-Restrepo, M., Gaiteri, C., Myers, A. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.016 · Cited by 147
Review: neuropathology of non-tau frontotemporal lobar degeneration
Neumann, M., & Mackenzie, I. R. A. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12526 · Cited by 144 · cited 3×
“18 is poorly understood, with the FTLD‐UPS aggregates either representing an unknown diseasespecific protein or a more general defect in endosomal trafficking and lysosomal protein degradation (Neumann and Mackenzie, 2019).”
Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease
Lindquist, S., Duno, M., Batbayli, M., Puschmann, A., Braendgaard, H., Mardosiene, S., Svenstrup, K., Pinborg, L., Vestergaard, K., Hjermind, L., et al. (2013) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01903.x · Cited by 143 · cited 1×
“Huntington’s disease-like syndrome, progressive muscular atrophy, or corticobasal or ataxic syndromes (Anor et al., 2015; Lesage et al., 2013; Lindquist et al., 2013; Liu et al., 2014).”
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients
Cistaro, A., Pagani, M., Montuschi, A., Calvo, A., Moglia, C., Canosa, A., Restagno, G., Brunetti, M., Traynor, B. J., Nobili, F., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2667-5 · Cited by 129
Profiles of white matter tract pathology in frontotemporal dementia
Mahoney, C. J., Ridgway, G. R., Malone, I. B., Downey, L. E., Beck, J., Kinnunen, K. M., Schmitz, N., Golden, H. L., Rohrer, J. D., Schott, J. M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22468 · Cited by 124
Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration
Chen-Plotkin, A. S., Martinez-Lage, M., Sleiman, P. M. A., Hu, W., Greene, R., Wood, E. M., Bing, S., Grossman, M., Schellenberg, G. D., Hatanpaa, K. J., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.53 · Cited by 120
Mahoney, C. J., Downey, L. E., Ridgway, G. R., Beck, J., Clegg, S., Blair, M., Finnegan, S., Leung, K. K., Yeatman, T., Golden, H., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt144 · Cited by 114
Broad, R. J., Gabel, M. C., Dowell, N. G., Schwartzman, D. J., Seth, A. K., Zhang, H., Alexander, D. C., Cercignani, M., & Leigh, P. N. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318830 · Cited by 105
Patterns of microglial cell activation in frontotemporal lobar degeneration
Lant, S. B., Robinson, A. C., Thompson, J. C., Rollinson, S., Pickering‐Brown, S., Snowden, J. S., Davidson, Y. S., Gerhard, A., & Mann, D. M. A. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12092 · Cited by 102 · cited 1×
“Other PET studies have reported high levels of microglial activation in MAPT-FTD postmortem (Lant et al., 2014) and dopaminergic dysfunction and glial activation in presymptomatic carriers (Bevan-Jones et al., 2019; Miyoshi et al., 2010; Wu et al., 2018).”
BackgroundLongitudinal diffusion tensor imaging in frontotemporal dementia
Mahoney, C. J., Simpson, I. J. A., Nicholas, J. M., Fletcher, P. D., Downey, L. E., Golden, H. L., Clark, C. N., Schmitz, N., Rohrer, J. D., Schott, J. M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24296 · Cited by 101
Van Mossevelde, S., van der Zee, J., Gijselinck, I., Engelborghs, S., Sieben, A., Van Langenhove, T., De Bleecker, J., Baets, J., Vandenbulcke, M., Van Laere, K., et al. (2016) · Brain · doi:10.1093/brain/awv358 · Cited by 98 · cited 9×
“…imaging on pure ALS and FTD-ALS due to TBK1 mutations have described variable vulnerable brain regions, but involvement of temporal cortex, hippocampi, and cerebellum appear common across various reports (Jiao et al., 2018; McCombe et al., 2018; Tohnai et al., 2018; Van Mossevelde et al., 2016).”
BackgroundInfluentialDisrupted brain connectome in semantic variant of primary progressive aphasia
Agosta, F., Galantucci, S., Valsasina, P., Canu, E., Meani, A., Marcone, A., Magnani, G., Falini, A., Comi, G., & Filippi, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.017 · Cited by 94
Vijverberg, E. G. B., Wattjes, M. P., Dols, A., Krudop, W. A., Möller, C., Peters, A., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160285 · Cited by 92 · cited 2×
“…et al., 2017a; Diehl-Schmid et al., 2007; Morbelli et al., 2016; Tosun et al., 2016; Verfaillie et al., 2015; Vijverberg et al., 2016), yet frontal hypometabolism has also been reported in psychiatric disorders and Alzheimer's disease, which confounds diagnostic accuracy (Vijverberg et al., 2016).”
BackgroundLam, B. Y. K., Halliday, G. M., Irish, M., Hodges, J. R., & Piguet, O. (2014) · Human Brain Mapping · doi:10.1002/hbm.22420 · Cited by 90 · cited 3×
“Axonal degeneration, likely associated with gray matter neuron loss, often arises in the anterior corpus callosum, cingulum bundle and uncinate fasciculus (Agosta et al., 2012; Elahi et al., 2017; Lam et al., 2014; Mahoney et al., 2015, 2014; Whitwell et al., 2010; Zhang et al., 2013).”
BackgroundKarch, C. M., Wen, N., Fan, C. C., Yokoyama, J. S., Kouri, N., Ross, O. A., Höglinger, G., Müller, U., Ferrari, R., Hardy, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0372 · Cited by 89
Characteristics of frontotemporal dementia patients with a Progranulin mutation
Huey, E. D., Grafman, J., Wassermann, E. M., Pietrini, P., Tierney, M. C., Ghetti, B., Spina, S., Baker, M., Hutton, M., Elder, J. W., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20969 · Cited by 87 · cited 1×
“corresponding to regional atrophy patterns seen in structural imaging (Cruchaga et al., 2009; Huey et al., 2006).”
FUS and TDP43 genetic variability in FTD and CBS
Huey, E. D., Ferrari, R., Moreno, J. H., Jensen, C., Morris, C. M., Potocnik, F., Kalaria, R. N., Tierney, M., Wassermann, E. M., Hardy, J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.004 · Cited by 82 · cited 1×
“Studies in patients with FTD or FTD-ALS with FUS mutations have reported frontal, temporal and parietal atrophy and hypometabolism (Akiyama et al., 2016; Blair et al., 2010; Broustal et al., 2010; Huey et al., 2012).”
Longitudinal imaging in C9ORF72 mutation carriers: relationship to phenotype
Floeter, M. K., Bageac, D., Danielian, L. E., Braun, L. E., Traynor, B. J., & Kwan, J. Y. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.10.014 · Cited by 75 · cited 7×
“In C9orf72-ALS, metabolic signatures are more variable (Castelnovo et al., 2019).”
InfluentialMiyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75
Salience Network Resting-State Activity: Prediction of Frontotemporal Dementia Progression
Day, G. S., Farb, N. A. S., Tang-Wai, D. F., Masellis, M., Black, S. E., Freedman, M., Pollock, B. G., & Chow, T. W. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3258 · Cited by 73
In vivo 18 F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
Jones, D. T., Knopman, D. S., Graff-Radford, J., Syrjanen, J. A., Senjem, M. L., Schwarz, C. G., Dheel, C., Wszolek, Z., Rademakers, R., Kantarci, K., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005117 · Cited by 71 · cited 1×
“[18F]AV-1451, however, has shown strong binding to neurofibrillary tangles matching the pattern of paired helical filament (PHF) immunochemistry in a subset of MAPT mutations such as V337M and R406W (Jones et al., 2018; Smith et al., 2016; Tsai et al., 2019).”
BackgroundDopper, E. G. P., Chalos, V., Ghariq, E., den Heijer, T., Hafkemeijer, A., Jiskoot, L. C., de Koning, I., Seelaar, H., van Minkelen, R., van Osch, M. J. P., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.08.001 · Cited by 57
Longitudinal diffusion imaging across the C9orf72 clinical spectrum
Floeter, M. K., Danielian, L. E., Braun, L. E., & Wu, T. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316799 · Cited by 51
Olney, N. T., Ong, E., Goh, S. M., Bajorek, L., Dever, R., Staffaroni, A. M., Cobigo, Y., Bock, M., Chiang, K., Ljubenkov, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.08.196 · Cited by 46
UBQLN2 mutations are rare in French and French–Canadian amyotrophic lateral sclerosis
Daoud, H., Suhail, H., Szuto, A., Camu, W., Salachas, F., Meininger, V., Bouchard, J.-P., Dupré, N., Dion, P. A., & Rouleau, G. A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.015 · Cited by 42
In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
Bevan‐Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T., Arnold, R., Coles, J. P., Aigbirhio, F. I., O'Brien, J. T., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.683 · Cited by 36
Rates of lobar atrophy in asymptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Senjem, M., Tosakulwong, N., Lesnick, T. G., Brushaber, D., Dheel, C., Fields, J., Forsberg, L., Gavrilova, R., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.05.010 · Cited by 28
Cited by
Cardiolipin, Mitochondria, and Neurological Disease
Falabella, M., Vernon, H. J., Hanna, M. G., Claypool, S. M., & Pitceathly, R. D. S. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.01.006 · Cited by 282
“Clinical and molecular overlap between FTD and ALS exists with mutations in C9orf72, TARDBP, FUS, TANK-binding kinase 1 (TBK1), valosin containing protein (VCP), coiled-coil-helix-coiledcoil-helix domain containing 10 (CHCHD10), and sequestosome-1 (SQSTM1) [54], suggesting that the two disorders share common pathophys…”
BackgroundAdvances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
Ilieva, H., Vullaganti, M., & Kwan, J. (2023) · BMJ · doi:10.1136/bmj-2023-075037 · Cited by 111
Peet, B. T., Spina, S., Mundada, N., & La Joie, R. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01101-x · Cited by 74
Metadata
- Authors
- Häkkinen, S., Chu, S. A., & Lee, S. E.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 145
- Pages
- 105063
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W3081830441
- Cited by
- 43
- References
- 79
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.